IP Library › Granted Patent US 10,611,996
Granted Patent B2
US 10,611,996 · App. 15/416,903 · Granted Apr 7, 2020

Preservation and storage of biological specimens

Inventor: James C. Copeland (Mansfield, OH)
Assignee: OXYRASE, INC.
C12N1/04A01N1/0221A01N1/0284
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,611,996
App. No.
15/416,903
Granted
Apr 7, 2020
Kind
B2
Abstract

Methods of preserving and storing biological specimens, particularly anaerobe microorganisms are disclosed. A composition containing oxygen scavenging membrane fragments and a cryoprotectant is administered to the specimens. The specimens are then stored at a temperature that is lower than 0° C. and greater than −70° C. Cryogenic freezing is not required.

Claims (13)

1. A method for storing biological specimens, comprising (i) suspending a sample of the biological specimens in a composition comprising a cryoprotectant and oxygen scavenging membrane fragments; and (ii) storing the sample suspended in the composition at a temperature below 0° C., wherein the composition remains in a continuous liquid state throughout storage;

wherein the cryoprotectant is ethylene glycol, propylene glycol, glycerol, a polyethylene glycol, or dimethyl sulfoxide (DMSO); and

wherein the composition contains from about 15 wt % to about 65 wt % of the cryoprotectant.

2. The method of claim 1 , wherein the oxygen scavenging membrane fragments are derived from the cytoplasmic membranes of Escherichia coli, Salmonella typhimurium, Gluconobacter oxydans, Pseudomonas aeruginosa , or Acetobacter.

3. The method of claim 1 , wherein the composition further comprises a hydrogen donating substance.

4. The method of claim 3 , wherein the hydrogen donating substance is lactic acid, succinic acid, alpha-glycerol phosphate, formic acid, malic acid, or a salt thereof.

5. The method of claim 3 , wherein the hydrogen donating substance is present in the amount of about 1 wt % to about 5 wt % of the composition.

6. The method of claim 1 , wherein the composition is in the form of a suspension.

7. The method of claim 1 , wherein the composition contains the oxygen scavenging membrane fragments in an amount greater than 0.01 units per milliliter or greater than 0.5 units per milliliter, or greater than 1 unit per milliliter, or from 1 unit per milliliter to 10 units per milliliter, or from 5 units per milliliter to 10 units per milliliter, or from 10 units per milliliter to 50 units per milliliter.

8. The method of claim 1 , wherein the sample is stored at a temperature range of from about −25° C. to about −5° C.

9. The method of claim 1 , wherein the cryoprotectant is glycerol or a polyethylene glycol.

10. The method of claim 1 , wherein the composition is first placed in a container, and an oil layer is then overlaid onto the composition.

11. The method of claim 1 , wherein the biological specimens are anaerobe bacteria selected from the group consisting of Bacteroides fragilis, Bifidobacterium adolescentis, Clostridium perfringens, Fusobacterium nucleatum, Porphyromonas levii, Peptostreptococcus anaerobius, Prevotella melaninogenica , and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2017
From: COPELAND, JAMES C.
To: OXYRASE, INC.
Reel/Frame 041097/0045 →
Continuity (2)
Provisional Application 62288042 · Jan 28, 2016
Related Publication 20170218325A1 · Aug 3, 2017
Cited By (2)
US 12,426,594 US 12,453,805